H&E staining results showed that the STING agonist potently inhibited metastasis, and the addition of B-cell depletion further enhanced this ability, showing the enhanced effect of STING agonist and B-cell depletion in the control of HCC metastasis (Fig. S6E). This evidence concerns the gene STING1 and hepatocellular carcinoma.